Pfizer’s bivalent vaccine for Omicron variant approved by Health Canada

Canada News

The updated version of the Pfizer-BioNTech Comirnaty COVID-19 vaccine targeting the Omicron BA.4 and BA.5 subvariants was approved by Health Canada on Friday.

Credit CBC News